Vertex Pharmaceuticals Inc (VRTX)
408.80
+0.48
(+0.12%)
USD |
NASDAQ |
Jan 08, 12:07
Vertex Pharmaceuticals Research and Development Expense (TTM): 3.983B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Eli Lilly and Co | 10.53B |
Gilead Sciences Inc | 8.104B |
Pfizer Inc | 10.60B |
Bristol-Myers Squibb Co | 10.45B |
Viking Therapeutics Inc | 91.16M |